REQUEST A DEMO
Total
USD $0.00
Search more companies

Spectrum Clinical Research Private Limited (India)

Main Activities: Research and Development in the Social Sciences and Humanities
Full name: Spectrum Clinical Research Private Limited Profile Updated: August 17, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Spectrum Clinical Research Private Limited is an enterprise based in India. Its main office is in Mumbai. The company operates in the Research and Development in the Social Sciences and Humanities industry. It was first established on June 22, 2006. In 2025, the company reported a net sales revenue increase of 133.33%. During that time, Spectrum Clinical Research Private Limited’s total assets grew by 13.18%.

Headquarters
501 5Th Floor 37 Kshamalaya New Marine Lines Mumbai Mumbai City Unclassified Mh Mumbai In 400020
Mumbai; Maharashtra; Postal Code: 400020

Contact Details: Purchase the Spectrum Clinical Research Private Limited report to view the information.

Basic Information
Registered Capital:
Purchase the Spectrum Clinical Research Private Limited report to view the information.
Financial Auditors:
Purchase the Spectrum Clinical Research Private Limited report to view the information.
Incorporation Date:
June 22, 2006
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Company Performance
Financial values in the chart are available after Spectrum Clinical Research Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
133.33%▲
Total Operating Revenue
133.51%▲
Operating Profit
N/A
EBITDA
N/A
Net Profit/Loss for the Period
N/A
Total Assets
13.18%▲
Total Equity
3.95%▲
Operating Profit Margin
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt / Equity
-22.71%▼
Quick Ratio
-0.87%▼

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?